Home › Inflammatory Bowel Disease
Pag-aaral pangklinika para sa Inflammatory Bowel Disease na nagre-recruit sa U.S.
71 pag-aaral para sa Inflammatory Bowel Disease ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY18 pag-aaral
- Boston, MA15 pag-aaral
- Seattle, WA9 pag-aaral
- Miami, FL9 pag-aaral
- Durham, NC8 pag-aaral
- Orlando, FL8 pag-aaral
- Atlanta, GA8 pag-aaral
- Houston, TX8 pag-aaral
- Cincinnati, OH7 pag-aaral
- Washington, DC7 pag-aaral
- Philadelphia, PA7 pag-aaral
- St. Louis, MO7 pag-aaral
- Baltimore, MD6 pag-aaral
- Pittsburgh, PA5 pag-aaral
- San Diego, CA5 pag-aaral
- Providence, RI5 pag-aaral
- Round Rock, TX5 pag-aaral
- Ann Arbor, MI5 pag-aaral
- Los Angeles, CA5 pag-aaral
- Tyler, TX5 pag-aaral
- Mountain View, CA5 pag-aaral
- Garland, TX4 pag-aaral
- Colorado Springs, CO4 pag-aaral
- Chicago, IL4 pag-aaral
- Lewisville, TX4 pag-aaral
- Cleveland, OH4 pag-aaral
- Milwaukee, WI4 pag-aaral
- Hartford, CT4 pag-aaral
- Fort Worth, TX4 pag-aaral
- Tampa, FL4 pag-aaral
- Cedar Rapids, IA3 pag-aaral
- New Orleans, LA3 pag-aaral
- League City, TX3 pag-aaral
- Lancaster, CA3 pag-aaral
- San Antonio, TX3 pag-aaral
- Louisville, KY3 pag-aaral
- Tacoma, WA3 pag-aaral
- Evanston, IL3 pag-aaral
- New Haven, CT3 pag-aaral
- Charlotte, NC3 pag-aaral
Ayos sa estado
- Arizona6 pag-aaral
- Arkansas3 pag-aaral
- California18 pag-aaral
- Colorado5 pag-aaral
- Connecticut8 pag-aaral
- Florida11 pag-aaral
- Georgia9 pag-aaral
- Illinois7 pag-aaral
- Iowa3 pag-aaral
- Kansas3 pag-aaral
- Kentucky4 pag-aaral
- Louisiana6 pag-aaral
- Maryland11 pag-aaral
- Massachusetts15 pag-aaral
- Michigan6 pag-aaral
- Minnesota3 pag-aaral
- Mississippi3 pag-aaral
- Missouri7 pag-aaral
- Nevada3 pag-aaral
- New Jersey5 pag-aaral
- New York21 pag-aaral
- North Carolina14 pag-aaral
- Ohio15 pag-aaral
- Pennsylvania11 pag-aaral
- Rhode Island5 pag-aaral
- South Carolina4 pag-aaral
- Tennessee7 pag-aaral
- Texas16 pag-aaral
- Utah3 pag-aaral
- Virginia6 pag-aaral
- Washington10 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06598943Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07619547A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07845487Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06619990Immune Regulation in Ulcerative Colitis or Crohn s Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 75 Years · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00001184Non-nutritive Sweeteners in Inflammatory Bowel Disease
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05923073Study of DISC-0974-201 in Participants With IBD and Anemia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07368972Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04685200A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Nagre-recruitPhase 3
Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04844606A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06226883Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07513181Observational Pharmaco-Epidemiology Research & Analysis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 0 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT03813862Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Nagre-recruitObservasyonal na pag-aaral
1 Month – 115 Years · Lahat ng kasarian · Na-update Set 9, 2026 · NCT00001456A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
Nagre-recruitPhase 4
3 Weeks · Kababaihan · Na-update Set 8, 2026 · NCT07612267Familial Inflammatory Bowel Disease Early Risk
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 0 hanggang 55 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07791862A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05509777Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06274554A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 45 · Kababaihan · Na-update Ago 11, 2026 · NCT00904878BOOM-IBD2 Pivotal Clinical Trial
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06571669HB-adMSCs for the Treatment of Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07077746Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07237516Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT02997293Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.